Inmunología, Microbiología y Parasitología
Departamento
Hospital Universitario de Valme
Sevilla, EspañaPublicaciones en colaboración con investigadoras/es de Hospital Universitario de Valme (26)
2022
-
In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
Frontiers in Cellular and Infection Microbiology, Vol. 12
2020
-
GEHEP 010 study: Prevalence and distribution of hepatitis B virus genotypes in Spain (2000–2016)
Journal of Infection, Vol. 81, Núm. 4, pp. 600-606
2019
-
Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 1
2018
-
Developing collaborative works for faster progress on fungal respiratory infections in cystic fibrosis
Medical Mycology, Vol. 56, pp. S42-S59
2012
-
Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 5, pp. 1181-1187
-
The undiagnosed cases of Clostridium difficile infection in a whole nation: Where is the problem?
Clinical Microbiology and Infection, Vol. 18, Núm. 7
2011
-
Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454
-
Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia
Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 12, pp. 5590-5596
-
Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC) guidelines for the diagnosis of invasive fungal infections. 2010 Update
Enfermedades Infecciosas y Microbiologia Clinica
2010
-
Evaluation of the VITEK 2 system to test the susceptibility of Candida spp., Trichosporon asahii and Cryptococcus neoformans to amphotericin B, flucytosine, fluconazole and voriconazole: A comparison with the M27-A3 reference method
Medical Mycology, Vol. 48, Núm. 5, pp. 710-719
-
Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in Spain
Journal of Clinical Microbiology, Vol. 48, Núm. 11, pp. 4200-4206
-
Vacunas frente al virus del papiloma humano: Actualización
Clinica e Investigacion en Ginecologia y Obstetricia
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
2007
-
Update on invasive fungal infections: the last two years
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 19-27
2005
-
Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: Correlation with results of NCCLS M27-A2 multicenter study
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 4, pp. 1604-1607
2004
-
In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts
Revista Iberoamericana de Micologia, Vol. 21, Núm. 2, pp. 63-69
2002
2000
-
Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole
Chemotherapy, Vol. 46, Núm. 4, pp. 235-244
-
In vitro activity of a new liposomal nystatin formulation against opportunistic fungal pathogens
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 19, Núm. 8, pp. 645-648
-
In vitro susceptibility of Candida dubliniensis to current and new antifungal agents
Chemotherapy, Vol. 46, Núm. 6, pp. 395-401